A Two-Centre, Randomised, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Period Cross-Over Study to Evaluate the Effect of Treatment With Repeat Doses of GW274150 on the Allergen-Induced Late Asthmatic Response in Subjects With Mild Asthma.

Trial Profile

A Two-Centre, Randomised, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Period Cross-Over Study to Evaluate the Effect of Treatment With Repeat Doses of GW274150 on the Allergen-Induced Late Asthmatic Response in Subjects With Mild Asthma.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs GW 274150; Montelukast
  • Indications Asthma
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 24 Mar 2009 Actual initiation date changed from Jan 2005 to Nov 2004; trial phase changed from II to I as reported by ClinicalTrials.gov.
    • 09 Mar 2008 Status change
    • 05 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top